Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

Related Articles by Review for PubMed (Select 18165284)

1.

The role of recombinant human insulin-like growth factor-I in treating children with short stature.

Collett-Solberg PF, Misra M; Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society.

J Clin Endocrinol Metab. 2008 Jan;93(1):10-8. doi: 10.1210/jc.2007-1534. Epub 2007 Dec 28. Review.

PMID:
18165284
2.

Insulin-like growth factor-I (rhIGF-I) therapy of short stature.

Rosenbloom AL.

J Pediatr Endocrinol Metab. 2008 Apr;21(4):301-15. Review.

PMID:
18556960
3.

Recombinant human insulin-like growth factor-I therapy for children with growth disorders.

Richmond EJ, Rogol AD.

Adv Ther. 2008 Dec;25(12):1276-87. doi: 10.1007/s12325-008-0124-9. Review.

PMID:
19066756
6.

Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.

Kemp SF.

BioDrugs. 2009;23(3):155-63. doi: 10.2165/00063030-200923030-00002. Review.

PMID:
19627167
7.

Mecasermin (recombinant human insulin-like growth factor I).

Rosenbloom AL.

Adv Ther. 2009 Jan;26(1):40-54. doi: 10.1007/s12325-008-0136-5. Epub 2009 Jan 28. Review.

PMID:
19198769
8.

Recombinant human IGF-1 (insulin-like growth factor) therapy: where do we stand today?

Balhara B, Misra M, Levitsky LL.

Indian J Pediatr. 2012 Feb;79(2):244-9. doi: 10.1007/s12098-011-0608-5. Epub 2011 Nov 17. Review.

PMID:
22090255
9.

Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure.

Clark RG.

Pediatr Nephrol. 2005 Mar;20(3):290-4. Epub 2005 Jan 29. Review.

PMID:
15682316
10.

Principles of growth hormone and insulin-like growth factor-I treatment in children with idiopathic short stature.

Bang P.

Horm Res Paediatr. 2011;76 Suppl 3:24-6. doi: 10.1159/000330148. Epub 2011 Sep 7. Review.

PMID:
21912155
11.

Growth hormone-resistant syndromes: long-term follow-up.

Chernausek SD.

Endocr Dev. 2009;14:135-42. doi: 10.1159/000207482. Epub 2009 Feb 27. Review.

PMID:
19293580
12.

Recombinant human insulin-like growth factor-1 treatment: ready for primetime.

Bright GM, Mendoza JR, Rosenfeld RG.

Endocrinol Metab Clin North Am. 2009 Sep;38(3):625-38. doi: 10.1016/j.ecl.2009.06.003. Review.

PMID:
19717008
13.

Treatment of dwarfism with recombinant human insulin-like growth factor-1.

Ranke MB, W├Âlfle J, Schnabel D, Bettendorf M.

Dtsch Arztebl Int. 2009 Oct;106(43):703-9. doi: 10.3238/arztebl.2009.0703. Epub 2009 Oct 23. Review.

14.
15.

Insulin-like growth factor-I in growth and metabolism.

Backeljauw P, Bang P, Dunger DB, Juul A, Le Bouc Y, Rosenfeld R.

J Pediatr Endocrinol Metab. 2010 Jan-Feb;23(1-2):3-16. Review.

PMID:
20432800
16.

Identification and management of poor response to growth-promoting therapy in children with short stature.

Bang P, Ahmed SF, Argente J, Backeljauw P, Bettendorf M, Bona G, Coutant R, Rosenfeld RG, Walenkamp MJ, Savage MO.

Clin Endocrinol (Oxf). 2012 Aug;77(2):169-81. doi: 10.1111/j.1365-2265.2012.04420.x. Review.

PMID:
22540980
17.

GH, IGF-I, and growth.

Isaksson O.

J Pediatr Endocrinol Metab. 2004 Sep;17 Suppl 4:1321-6. Review.

PMID:
15506078
18.

Current and potential therapeutic uses of growth hormone and insulin-like growth factor I.

Hintz RL.

Endocrinol Metab Clin North Am. 1996 Sep;25(3):759-73. Review.

PMID:
8879998
19.

Update in growth hormone therapy of children.

Collett-Solberg PF.

J Clin Endocrinol Metab. 2011 Mar;96(3):573-9. doi: 10.1210/jc.2010-1131. Review.

PMID:
21378219
20.

Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement.

Mahan JD, Warady BA; Consensus Committee.

Pediatr Nephrol. 2006 Jul;21(7):917-30. Epub 2006 May 30.

PMID:
16773402
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk